These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 33940779)

  • 1. Granulocyte-colony stimulating factor, a potential candidate for the treatment of Parkinson's disease.
    Yuan J; Xue LX; Ren JP
    J Neurosurg Sci; 2024 Oct; 68(5):558-566. PubMed ID: 33940779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
    Meuer K; Pitzer C; Teismann P; Krüger C; Göricke B; Laage R; Lingor P; Peters K; Schlachetzki JC; Kobayashi K; Dietz GP; Weber D; Ferger B; Schäbitz WR; Bach A; Schulz JB; Bähr M; Schneider A; Weishaupt JH
    J Neurochem; 2006 May; 97(3):675-86. PubMed ID: 16573658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic influence of chronic oral administration of paraquat on nigrostriatal dopaminergic neurons in C57BL/6 mice.
    Ren JP; Zhao YW; Sun XJ
    Chin Med J (Engl); 2009 Oct; 122(19):2366-71. PubMed ID: 20079141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-MPTP treatment with granulocyte colony-stimulating factor improves nigrostriatal function in the mouse model of Parkinson's disease.
    McCollum M; Ma Z; Cohen E; Leon R; Tao R; Wu JY; Maharaj D; Wei J
    Mol Neurobiol; 2010 Jun; 41(2-3):410-9. PubMed ID: 20405343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
    Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
    Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.
    Rai SN; Yadav SK; Singh D; Singh SP
    J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.
    Thiruchelvam M; Richfield EK; Baggs RB; Tank AW; Cory-Slechta DA
    J Neurosci; 2000 Dec; 20(24):9207-14. PubMed ID: 11124998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice.
    Shepherd KR; Lee ES; Schmued L; Jiao Y; Ali SF; Oriaku ET; Lamango NS; Soliman KF; Charlton CG
    Pharmacol Biochem Behav; 2006 Mar; 83(3):349-59. PubMed ID: 16580056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.
    Guo Z; Xu S; Du N; Liu J; Huang Y; Han M
    Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
    Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T
    Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic metalloporphyrin protects against paraquat neurotoxicity in vivo.
    Chen P; Chen Z; Li A; Lou XC; Wu XK; Zhao CJ; Wang SL; Liang LP
    Biomed Environ Sci; 2008 Jun; 21(3):233-8. PubMed ID: 18714822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraquat induces alternation of the dopamine catabolic pathways and glutathione levels in the substantia nigra of mice.
    Kang MJ; Gil SJ; Koh HC
    Toxicol Lett; 2009 Jul; 188(2):148-52. PubMed ID: 19446248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of pomegranate (Punica granatum L.) juice and seed extract in paraquat-induced mouse model of Parkinson's disease.
    Fathy SM; El-Dash HA; Said NI
    BMC Complement Med Ther; 2021 Apr; 21(1):130. PubMed ID: 33902532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
    Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
    Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX; Chen WF; Xie JX; Wong MS
    Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraquat induces selective dopaminergic nigrostriatal degeneration in aging C57BL/6 mice.
    Li X; Yin J; Cheng CM; Sun JL; Li Z; Wu YL
    Chin Med J (Engl); 2005 Aug; 118(16):1357-61. PubMed ID: 16157030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of kaempferol against a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Li S; Pu XP
    Biol Pharm Bull; 2011; 34(8):1291-6. PubMed ID: 21804220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential target for the treatment of Parkinson's disease: effect of lateral habenula lesions.
    Han B; Jin HJ; Song MY; Wang T; Zhao H
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1191-5. PubMed ID: 25219971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
    Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.